1.745

8.39% 0.135

Clarivate Plc (CLVT)

Overview News Price History Option Chain Financials Discussions Forecast

Clarivate Plc stock is traded at $1.745, with a volume of 1.81M. It is up +8.39% in the last 24 hours and down -8.16% over the past month. Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas, while Europe, Middle East, and Africa account for around a quarter.

Previous Close:

$1.61

Open:

$1.65

24h Volume:

1.81M

Relative Volume:

0.54

Market Cap:

$1.12B

Revenue:

$2.45B

Net Income/Loss:

$-137.40M

P/E Ratio:

-8.4668

EPS:

-0.2061

Net Cash Flow:

$333.90M

1W Performance:

+7.06%

1M Performance:

-8.16%

6M Performance:

-29.64%

1Y Performance:

-52.32%

1-Day Range:

$1.62

$1.76

1-Week Range:

$1.54

$1.65

52-Week Range:

$1.42

$3.87

Clarivate Plc Stock (CLVT) Company Profile

Name

Clarivate Plc

Sector

Technology (800)

Industry

Information Technology Services (79)

Phone

(207) 433-4000

Address

4TH FLOOR, ST. PAUL'S GATE, ST. HELIER

Employee

12,000

Twitter

Next Earnings Date

2026-11-03

Latest SEC Filings

CLVT's Discussions on Twitter

Compare CLVT vs IBM, ACN, INFY, CTSH, FISV

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CLVT Clarivate Plc	1.745	1.12B	2.45B	-137.40M	333.90M	-0.2061
IBM International Business Machines Corp	233.24	219.74B	68.91B	10.73B	12.26B	11.31
ACN Accenture Plc	225.84	138.20B	73.10B	7.94B	12.58B	12.52
INFY Infosys Ltd Adr	12.16	49.27B	20.21B	3.33B	3.87B	0.8084
CTSH Cognizant Technology Solutions Corp	65.47	29.49B	21.41B	2.23B	2.47B	4.6058
FISV Fiserv Inc	46.92	24.95B	21.09B	3.22B	4.17B	5.8948

Clarivate Plc Stock (CLVT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-08-26	Downgrade	Goldman	Buy → Neutral
Dec-17-25	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Sep-03-25	Initiated	Wolfe Research	Peer Perform
Jul-18-25	Downgrade	Jefferies	Buy → Hold
Nov-06-24	Downgrade	William Blair	Outperform → Mkt Perform
Dec-15-23	Downgrade	Wells Fargo	Equal Weight → Underweight
Oct-16-23	Upgrade	Jefferies	Hold → Buy
Sep-08-23	Downgrade	Barclays	Equal Weight → Underweight
Aug-25-23	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Aug-07-23	Downgrade	BofA Securities	Neutral → Underperform
Aug-04-23	Downgrade	Wells Fargo	Overweight → Equal Weight
Jun-13-23	Initiated	Oppenheimer	Outperform
Mar-15-23	Resumed	BofA Securities	Neutral
Feb-06-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jul-13-22	Initiated	Wells Fargo	Overweight
Feb-04-22	Downgrade	Citigroup	Buy → Neutral
Feb-03-22	Downgrade	Barclays	Overweight → Equal Weight
Dec-21-21	Resumed	Citigroup	Buy
Dec-13-21	Resumed	Goldman	Buy
Aug-16-21	Initiated	BofA Securities	Buy
Aug-04-21	Resumed	RBC Capital Mkts	Outperform
Mar-31-21	Initiated	Jefferies	Buy
Mar-11-21	Resumed	Citigroup	Buy
Mar-08-21	Upgrade	Morgan Stanley	Equal-Weight → Overweight

View All

Clarivate Plc Stock (CLVT) Latest News

Oct 09, 2026

Altaris Completes Acquisition of Clarivate’s Life Sciences & Healthcare Business - Clarivate

Oct 06, 2026

Clarivate Divests Life Sciences Unit to Refocus Core - TipRanks

Oct 06, 2026

Clarivate Completes $600 Million Sale of Life Sciences & Healthcare Segment - marketscreener.com

Oct 06, 2026

Clarivate Completes $600 Million Sale of Life Sciences & Healthcare Segment - Yahoo Finance

Oct 06, 2026

CLARIVATE PLC Announces Termination of Henry Levy's Employment as President, Life Sciences & Healthcare, Effective October 6, 2026 - www.marketscreener.com

Oct 06, 2026

Clarivate Completes Sale of Life Sciences & Healthcare Segment, Advances Strategic Transformation - Morningstar

Oct 06, 2026

Clarivate Completes Sale of Life Sciences & Healthcare Segment, Advances Strategic Transformation - PR Newswire

Oct 06, 2026

Oct 05, 2026

What Does Clarivate (NYSE:CLVT) New Low Signal on NYSE? - Kalkine Media

Oct 05, 2026

Clarivate (NYSE:CLVT) Hits New 12-Month LowWhat's Next? - MarketBeat

Oct 05, 2026

Oct 04, 2026

Clarivate: Pricing The Worst, As The Business Still Has Chances (NYSE:CLVT) - Seeking Alpha

Oct 04, 2026

Oct 02, 2026

Clarivate Stock Price Forecast. Should You Buy CLVT? - StockInvest.us

Oct 02, 2026

Shares replace a $51,250 cash retainer for Clarivate (CLVT) director Andrew Miles Snyder. - Stock Titan

Oct 02, 2026

Clarivate (NYSE:CLVT) Stock Falls 5.9%Here's Why - MarketBeat

Oct 02, 2026

Clarivate (CLVT) Institutional Ownership 2026 $CLVT - MarketBeat

Oct 02, 2026

Sep 30, 2026

Clarivate : IPfolio Selected by Topcon - marketscreener.com

Sep 30, 2026

Sep 29, 2026

Clarivate Plc stock hits 52-week low at 1.65 USD By Investing.com - Investing.com Nigeria

Sep 29, 2026

Clarivate Plc stock hits 52-week low at 1.65 USD By Investing.com - Investing.com South Africa

Sep 29, 2026

Clarivate Plc stock hits 52-week low at 1.65 USD - Investing.com

Sep 29, 2026

Clarivate (NYSE:CLVT) Hits New 1-Year LowWhat's Next? - MarketBeat

Sep 29, 2026

Sep 25, 2026

Clarivate PLC (16A.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 25, 2026

Sep 24, 2026

Clarivate Plc Announces Completion and Results of Debt Tender Offer by Subsidiary - Kalkine Media

Sep 24, 2026

Clarivate announces $75M accepted tender for 3.875% notes due 2028, proration 11.3% - TradingView

Sep 24, 2026

Holders tendered $665M in notes to a Clarivate (CLVT) subsidiary. Only a portion was accepted. - stocktitan.net

Sep 24, 2026